A surrogate-assisted evolutionary algorithm based on problem reconstruction and feature extraction for high-dimensional expensive multi-objective optimization problems
Applied Soft Computing · 2026-09 · 201 · 115673
DOI: 10.1016/j.asoc.2026.115673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Soft Computing, 2026-09. Verfasst von Xiangyang Zhu und 4 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions, National Natural Science Foundation of China, Natural Science Research of Jiangsu Higher Education Institutions of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
- National Natural Science Foundation of China
- Natural Science Research of Jiangsu Higher Education Institutions of China
- Jiangsu Province Natural Science Foundation
Zitieren
APA
Zhu, X., Xue, Y., Ping, L., Mohamed, A. W., & Mansour, R. F. (2026). A surrogate-assisted evolutionary algorithm based on problem reconstruction and feature extraction for high-dimensional expensive multi-objective optimization problems. Applied Soft Computing, 201, 115673. https://doi.org/10.1016/j.asoc.2026.115673
Vancouver
Zhu X, Xue Y, Ping L, Mohamed AW, Mansour RF. A surrogate-assisted evolutionary algorithm based on problem reconstruction and feature extraction for high-dimensional expensive multi-objective optimization problems. Applied Soft Computing. 2026;201:115673. doi:10.1016/j.asoc.2026.115673
BibTeX
@article{Zhu2026,
author = {Zhu, Xiangyang and Xue, Yu and Ping, Lanlan and Mohamed, Ali Wagdy and Mansour, Romany F.},
title = {A surrogate-assisted evolutionary algorithm based on problem reconstruction and feature extraction for high-dimensional expensive multi-objective optimization problems},
journal = {Applied Soft Computing},
year = {2026},
volume = {201},
pages = {115673},
doi = {10.1016/j.asoc.2026.115673}
}
EUVIMED